Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
J Drugs Dermatol ; 17(11): 1236-1240, 2018 11 01.
Article in English | MEDLINE | ID: mdl-30500148

ABSTRACT

We investigated a subtype of Telogen Effluvium associated with Dysesthesia, (TED) which was defined as the presence of Telogen Effluvium with severe itch, pain, soreness, burning, or formication in the absence of any inflammatory scalp disorder or medication associated with Telogen Effluvium or Dysesthesia. These are patients who present with a "burning" scalp or other dysesthesia associated with increased telogen hair shedding. Telogen Effluvium is not typically associated with any scalp symptoms.3 Other scalp dysesthesia studies have mentioned occasional patients in their study that were also diagnosed with Telogen Effluvium,1,2 but the clinical association of Scalp Dysesthesia and Telogen Effluvium has never been made as a distinct entity.


Subject(s)
Alopecia/diagnosis , Dietary Supplements , Hair Follicle/pathology , Paresthesia/diagnosis , Vitamin B 12/administration & dosage , Alopecia/blood , Alopecia/complications , Alopecia/drug therapy , Case-Control Studies , Female , Follow-Up Studies , Humans , Male , Middle Aged , Paresthesia/blood , Paresthesia/drug therapy , Paresthesia/etiology , Prospective Studies , Retrospective Studies , Scalp , Treatment Outcome , Vitamin B 12/blood
SELECTION OF CITATIONS
SEARCH DETAIL